(Reuters Health) - The first test in the United States of the CRISPR gene-editing tool in cancer appears to be safe, but it's too soon to know whether it's effective, U.S. researchers reported on Thursday in the journal Science.
Original Article: First U.S. attempt at CRISPR gene editing in cancer appears safe